Legevakten i Oslo
Oslo, 0182, Norway
NCT Number: NCT01132131
The Emergency Ward Center in Oslo has the last two years used a questionnaire to identify patients who qualify for treatment of acute cystitis by the use of a delegation form.
The aim of the study is to evaluate this practice, the primary objective being to evaluate if in a selected patient group the treatment outcome after identifying patients with probable acute cystitis by delegation form will be as good or better than the treatment received after a regular doctor's consultation.
The planned study will also investigate which symptoms, signs and laboratory findings that coincide with significant bacteruria.
The reference standard will be a microbiological culture of every patients urine.
Looking for future studies?
Notify Me16 year–55 year
Female
Interventional
Phase 4
Oslo, 0182, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The study aims to compare the use of a delegation form to identify patient's who qualify for antibiotic treatment for suspected acute cystitis with a regular doctor's consultation. The key outcomes are lack of bacteruria and symptoms of UTI at followup times.
Time frame: 6 days after start of treatment.
The antibiotic treatment given will be of three days length.
Time frame: 10 days after start of treatment
The antibiotic treatment will be of three days length
University of Oslo
Other
Use of Standardized Delegation Form in Diagnosing and Treating Acute Cystitis in Primary Care Facilities.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00305227
Cystitis, Female Urogenital Diseases
Seattle, Washington, United States
View Trial DetailsNCT01861353
Cystitis, Female Urogenital Diseases
Oulu, Finland
View Trial DetailsNCT01346774
Cystitis, Female Urogenital Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT00528476
Cystitis, Female Urogenital Diseases
Kaunas, Lithuania
View Trial Details